SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-047966
Filing Date
2008-03-05
Accepted
2008-03-05 17:16:09
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1102333
2 MASTER SECURITY AGREEMENT & PROMISSORY NOTES dex1013.htm EX-10.13 418056
3 FORM OF COMMON STOCK WARRANT dex1014.htm EX-10.14 56091
4 PROMISSORY NOTES & MASTER SECURITY AGREEMENT dex1028.htm EX-10.28 200172
5 CONSENT OF PROCEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1352
6 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9103
7 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9101
8 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3105
9 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 2961
10 GRAPHIC g69084g93t44.jpg GRAPHIC 63110
  Complete submission text file 0001193125-08-047966.txt   1890706
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33095 | Film No.: 08668692
SIC: 2834 Pharmaceutical Preparations